Search Results for "Next Choice"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Next Choice. Results 11 to 20 of 51 total matches.
See also: levonorgestrel

What Comes After Metformin for Type 2 Diabetes?

   
The Medical Letter on Drugs and Therapeutics • Jul 23, 2012  (Issue 1395)
on which drug should be added next. A recent article in The Medical Letter offered some support ...
Most experts agree that lifestyle modifications and metformin (Glucophage, and others) should be used first to treat patients with type 2 diabetes. If metformin alone fails to control hyperglycemia, there is no general agreement on which drug should be added next. A recent article in The Medical Letter offered some support for a sulfonylurea. Three recent trials published in The Lancet favored the long-acting basal insulin glargine, the glucagon-like peptide (GLP-1) analog exenatide, and the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin, respectively. Some of the advantages...
Med Lett Drugs Ther. 2012 Jul 23;54(1395):58-9 |  Show IntroductionHide Introduction

In Brief: A New OTC Naloxone Nasal Spray (RiVive)

   
The Medical Letter on Drugs and Therapeutics • Mar 18, 2024  (Issue 1698)
of choice for reversal of opioid overdose. Every state in the US now has a naloxone access law; in most ...
The FDA has approved RiVive (Harm Reduction Therapeutics), a 3-mg naloxone nasal spray, as an over-the-counter (OTC) product for emergency treatment of opioid overdose. Two 4-mg naloxone nasal spray formulations, Narcan and one of its generics, were approved for OTC sale in 2023.
Med Lett Drugs Ther. 2024 Mar 18;66(1698):47-8   doi:10.58347/tml.2024.1698d |  Show IntroductionHide Introduction

Colonoscopy Preparations

   
The Medical Letter on Drugs and Therapeutics • Jan 21, 2013  (Issue 1408)
Important Copyright Message IN THIS ISSUE (starts on next page) FORWARDING OR COPYING IS A VIOLATION ...
Colonoscopy remains the preferred method of colorectal cancer screening. Many patients consider cleansing the bowel in preparation for colonoscopy the most unpleasant part of the procedure, but inadequate bowel preparation significantly lowers the diagnostic yield.
Med Lett Drugs Ther. 2013 Jan 21;55(1408):6-7 |  Show IntroductionHide Introduction

Combination Oral Contraceptives and the Risk of Venous Thromboembolism

   
The Medical Letter on Drugs and Therapeutics • Mar 22, 2010  (Issue 1334)
Important Copyright Message IN THIS ISSUE (starts on next page) Combination Oral Contraceptives ...
Combination oral contraceptives increase the risk of venous thromboembolism (VTE). Their benefits, in addition to preventing pregnancy, include lowering the risk of ovarian and endometrial cancer, reducing dysfunctional uterine bleeding and increasing serum hemoglobin concentrations. Are these benefits worth the risk? And are some combination oral contraceptives safer than others?
Med Lett Drugs Ther. 2010 Mar 22;52(1334):23-4 |  Show IntroductionHide Introduction

Vancomycin Dosing and Monitoring

   
The Medical Letter on Drugs and Therapeutics • Apr 06, 2009  (Issue 1309)
Important Copyright Message IN THIS ISSUE (starts on next page) Vancomycin Dosing and Monitoring ...
Consensus recommendations for dosing and therapeutic monitoring of intravenous (IV) vancomycin (Vancocin, and others) were recently published. IV vancomycin has been used for decades as an alternative to penicillins for treatment of serious infections due to gram-positive cocci. In recent years, the widest use of the drug has been for treatment of serious methicillin-resistant Staphylococcus aureus (MRSA) infections.
Med Lett Drugs Ther. 2009 Apr 6;51(1309):25 |  Show IntroductionHide Introduction

A Diuretic for Initial Treatment of Hypertension?

   
The Medical Letter on Drugs and Therapeutics • Feb 09, 2009  (Issue 1305)
Important Copyright Message ARTICLE (starts on next page) A Diuretic for Initial Treatment ...
Effective treatment of hypertension can prevent organ damage and death. The choice of drugs for initial treatment continues to be controversial.
Med Lett Drugs Ther. 2009 Feb 9;51(1305):9-10 |  Show IntroductionHide Introduction

Expanded Table: Some Drugs for Altitude Illness, Jet Lag, and Motion Sickness (online only)

   
The Medical Letter on Drugs and Therapeutics • Oct 07, 2019  (Issue 1582)
conscious awareness, impaired next-day performance ▶ Increased risk of adverse cognitive effects ...
View the Expanded Table: Some Drugs for Altitude Illness, Jet Lag, and Motion Sickness
Med Lett Drugs Ther. 2019 Oct 7;61(1582):e161-3 |  Show IntroductionHide Introduction

In Brief: Injectable Paliperidone Palmitate for Schizophrenia

   
The Medical Letter on Drugs and Therapeutics • Nov 02, 2009  (Issue 1324)
Important Copyright Message IN THIS ISSUE (starts on next page) In Brief: Injectable Paliperidone ...
Paliperidone palmitate (Invega Sustenna – Ortho-McNeil Janssen) has been approved by the FDA as a once-monthly injection for acute and maintenance treatment of schizophrenia in adults. An extended-release oral formulation (Invega) has been available since 2006.1 Long-acting injections of antipsychotic drugs typically are used to treat patients who cannot adhere to an oral regimen.2,3 Paliperidone is the primary active metabolite of risperidone (Risperdal), which is also available as a long-acting (every 2 weeks) injection. It is unclear whether either risperidone or paliperidone is a better...
Med Lett Drugs Ther. 2009 Nov 2;51(1324):88 |  Show IntroductionHide Introduction

Opill — An OTC Oral Contraceptive

   
The Medical Letter on Drugs and Therapeutics • Sep 18, 2023  (Issue 1685)
of contraception should be used for the next 48 hours. Women who have a history of breast cancer, are pregnant ...
The FDA has approved Opill (Perrigo), a progestin-only oral contraceptive that contains norgestrel, for sale over the counter (OTC). Opill is the first oral contraceptive to be approved in the US for sale without a prescription. Approval of OTC Opill is intended to increase access to effective contraception and reduce the rate of unintended pregnancies.
Med Lett Drugs Ther. 2023 Sep 18;65(1685):151-2   doi:10.58347/tml.2023.1685c |  Show IntroductionHide Introduction

Intravenous Immunoglobulin (IVIG)

   
The Medical Letter on Drugs and Therapeutics • Dec 04, 2006  (Issue 1249)
. In addition to FDAapproved indications, IVIG is the treatment of choice, a good choice, a second-line ...
Intravenous immunoglobulin (IVIG) has 6 FDA approved indications and is prescribed off-label for many others. How many of these uses are justified is controversial.
Med Lett Drugs Ther. 2006 Dec 4;48(1249):101-2 |  Show IntroductionHide Introduction